| Description |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Pfizer
|
Carboplatin 150mg/15ml
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Himmel Pharma |
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Himmel Pharma
|
Carboplatin 150mg/15ml |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Beacon pharmaceuticals
|
Nab-Paclitaxel 100mg
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Pfizer
|
Cisplatin 50mg
|
| Product Type |
Product Size |
| Tablet |
20'S |
| Product Company |
| Mass Pharma |
Amlodipine 10mg
|
| Content | Carboplatin is a platinum-containing chemotherapy medicine, which belongs to the alkylating agents group of medicines. It is used to treat various cancers. It prevents growth of cancerous cells by damaging their DNA that aids in its proliferation.
| Docetaxel is a taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. | Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
| Protein-bound paclitaxel, also known as nanoparticle albumin- bound paclitaxel or nab paclitaxel, is an injectable formulation of paclitaxel used to treat breast cancer, lung cancer, and pancreatic cancer, among others.
| Cisplatin is a platinum based chemotherapy agent used to treat various sarcomas, carcinomas, lymphomas, and germ cell tumors. | Amlodipine, sold under the brand name Norvasc among others, is a calcium channel blocker medication used to treat high blood pressure and coronary artery disease. It is taken by mouth. |
Reviews
There are no reviews yet.